Atsushi Tanaka

机构：Teine Keijinkai Hospital, Teikyo University · ORCID：0000-0002-6358-5283

发表论文 344 篇 · 总被引 10990 次 · h-index 55

代表论文

• Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 23)
• Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis (2025 · Journal of Hepatology · 被引 14)
• Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 11)
• Bezafibrate for primary biliary cholangitis: time to act on the evidence (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 5)
• GS-011 Linerixibat significantly improves cholestatic pruritus in primary biliary cholangitis: results of the pivotal phase 3 GLISTEN trial (2025 · Journal of Hepatology · 被引 5)
• Nationwide survey of patients with acute liver failure and late‐onset hepatic failure in Japan seen between 2016 and 2021 (2025 · Hepatology Research · 被引 5)